Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Cellectis S.A. (CLLS)

« Back to company index

CLLS Chatter Timeline

Stock Ticker for CLLS

Most Active Tweeters for CLLS

UserTweets
@portefeuillefun 48
@AmericanBanking 10
@apppro1 7
@BehaviorFin 7
@BiotechRadar 7

Recent Tweets for CLLS

UlmHi @UlmHi
Comparison of Kodiak Sciences Inc. $CLLS https://t.co/PjKfj3aZbc
March 21st 2019, 4:03pm
SwingTradeBot @SwingTradeBot
20 DMA Support today: $BBN $CLLS ... https://t.co/deOpbNqdR6
March 21st 2019, 3:03pm
portefeuillefun @portefeuillefun
Sold 1k $CLLS at $18.62, now 20k #vssporte shares.
March 21st 2019, 2:03pm
portefeuillefun @portefeuillefun
Sold 2k $CLLS at $18.52, now 21k #vssporte shares.
March 21st 2019, 2:03pm
portefeuillefun @portefeuillefun
Sold 2k $CLLS at $18.40, now 23k #vssporte shares.
March 21st 2019, 1:03pm
portefeuillefun @portefeuillefun
One more day like today and the $CLLS CAR-T business will be valued at around 0 (while that of $ALLO is valued at a… https://t.co/IjbZDFJJiK
March 21st 2019, 1:03pm
portefeuillefun @portefeuillefun
Btw, there are also 25k $CLLS shares in the #vssporte portfolio, representing (via #Cellectis' 70% stake in #Calyxt… https://t.co/noydWcxei1
March 21st 2019, 12:03pm
SeekingAlpha @SeekingAlpha
$CLLS - Cellectis S.A. (CLLS) To Present At Oppenheimer 29th Annual Healthcare Conference - Slideshow https://t.co/xCIMWjYygd
March 21st 2019, 12:03pm
portefeuillefun @portefeuillefun
Bought 5k $CLLS at €16.00, now 25k #vssporte shares.
March 21st 2019, 9:03am
dhovekamp42 @dhovekamp42
@hanssherpa That was old $CLLS or nowadays old $ALLO approach
March 21st 2019, 9:03am
portefeuillefun @portefeuillefun
Can some investment bank please call @Arie_Belldegrun and explain to him how buying $CLLS with $ALLO shares (say 1.… https://t.co/BVMNPYEg7d
March 21st 2019, 9:03am
portefeuillefun @portefeuillefun
Bought 1k $CLLS at €15.96, now 20k #vssporte shares.
March 21st 2019, 9:03am
portefeuillefun @portefeuillefun
Bought 3k $CLLS at €16.15, now 19k #vssporte shares.
March 21st 2019, 9:03am
thefinreviewer @thefinreviewer
Rhythm Pharmaceuticals Inc. $CLLS Comparison side by side https://t.co/ZwWPVn1uSh
March 21st 2019, 7:03am
BehaviorFin @BehaviorFin
@portefeuillefun @AdamSinger I think one of the issues of $CLLS is that no US ETF or major US biotech fund is inves… https://t.co/z7AoEBZOy8
March 21st 2019, 5:03am
BehaviorFin @BehaviorFin
How do you explain difference of maket caps between $CLXT w TALEN from $CLLS vs other crop stocks using #crispr ? M… https://t.co/D5dezHgEVG
March 21st 2019, 4:03am
aschier1 @aschier1
The First Gene-Edited Food Is Now Being Served @Calyxt_Inc $CLLS #TALEN #NoCRISPR https://t.co/xPmXZTRd4a via @WIRED
March 21st 2019, 3:03am
mmahotstuff1 @mmahotstuff1
Oppenheimer Reaffirms The "Buy" Rating They’ve had for Cellectis SA $CLLS Shares https://t.co/3MdQw4gbWK
March 20th 2019, 10:03pm
whatsonthorold2 @whatsonthorold2
Oppenheimer Reconfirms Its "Buy" Rating on Cellectis SA $CLLS Shares Today https://t.co/HlY1WeZVvu
March 20th 2019, 10:03pm
bibeypost_stock @bibeypost_stock
Oppenheimer Reaffirms Its "Buy" Rating on Cellectis SA $CLLS Shares Today https://t.co/vISyugJawf
March 20th 2019, 10:03pm
reurope_stock @reurope_stock
Oppenheimer Reiterates "Buy" Rating for Cellectis SA $CLLS stock. What’s the Best Move for Investors? https://t.co/ENka41fF59
March 20th 2019, 10:03pm
UlmHi @UlmHi
Comparing of Novo Nordisk A/S $CLLS https://t.co/l83FfXLOzp
March 20th 2019, 6:03pm
portefeuillefun @portefeuillefun
Bought 800 $CLLS at $19.24, now 16k #vssporte shares.
March 20th 2019, 3:03pm
apppro1 @apppro1
RT @BiotechRadar: $CLLS tidbits at Oppenheimer HC Conf * @GruppSteve confirming the interest of targeting CD22 in R/R ALL, reporting almost…
March 20th 2019, 3:03pm
portefeuillefun @portefeuillefun
@AdamSinger $CLLS "consolidates the $CLXT cash" on their balance sheet, so you just need to be careful to not doubl… https://t.co/3vWBZ2yjfR
March 20th 2019, 2:03pm
portefeuillefun @portefeuillefun
@AdamSinger $CLXT could be a huge winner in the Ag field. I would just suggest owning them via $CLLS, the mother co… https://t.co/KznU1RAFPk
March 20th 2019, 2:03pm
portefeuillefun @portefeuillefun
Bought 200 $CLLS at $18.94, now 15.2k #vssporte shares.
March 20th 2019, 1:03pm
portefeuillefun @portefeuillefun
@BehaviorFin @AChoulika I think $CLXT is about fairly valued, if Cellectis' stake was distributed to $CLLS sharehol… https://t.co/EQoQjDmEIT
March 20th 2019, 1:03pm
portefeuillefun @portefeuillefun
Bought 200 $CLLS at $18.81, now 15k #vssporte shares.
March 20th 2019, 1:03pm
portefeuillefun @portefeuillefun
RT @BiotechRadar: UCART22 also to be dosed in naive ALL patients, not only R/R $CLLS $ALCLS https://t.co/3OGQkcuJsK
March 20th 2019, 1:03pm
thefinreviewer @thefinreviewer
Oppenheimer Keeps "Buy" Rating for Cellectis SA $CLLS Stock; Abbvie $ABBV Has 0.83 Sentiment https://t.co/nNB2nyVrW4
March 20th 2019, 12:03pm
BiotechRadar @BiotechRadar
UCART22 also to be dosed in naive ALL patients, not only R/R $CLLS $ALCLS https://t.co/3OGQkcuJsK
March 20th 2019, 10:03am
BiotechRadar @BiotechRadar
$CLLS tidbits at Oppenheimer HC Conf * @GruppSteve confirming the interest of targeting CD22 in R/R ALL, reporting… https://t.co/65cttimp8K
March 20th 2019, 10:03am
thefinreviewer @thefinreviewer
Bj's Wholesale Club Holdings $BJ Received Buy By Evercore ISI; Cellectis S.A. $CLLS Had 2 Bullish Analysts https://t.co/dTSzIts1en
March 20th 2019, 10:03am
TickerReport @TickerReport
FY2019 EPS Estimates for Cellectis SA $CLLS Lowered by Jefferies Financial Group https://t.co/in5p9kp88t
March 20th 2019, 1:03am
WatchlistN @WatchlistN
FY2019 EPS Estimates for Cellectis SA $CLLS Lowered by Jefferies Financial Group https://t.co/n8w11CeA4J
March 20th 2019, 1:03am
dispatchtribune @dispatchtribune
Cellectis $CLLS Upgraded by BidaskClub to Hold https://t.co/rN1QJqmPmj
March 20th 2019, 1:03am
BehaviorFin @BehaviorFin
$CLLS $ALCLS Where is major part of #Cellectis' value? I begin to wonder whether biggest value of Cellectis is in h… https://t.co/1JddQIO3Xn
March 19th 2019, 10:03am
portefeuillefun @portefeuillefun
$CLXT $CLLS. #Calyxt now up by roughly 100% from its December 21, 2018 low.
March 19th 2019, 9:03am
portefeuillefun @portefeuillefun
Sold 200 $CLLS at €17.30, now 14.8k #vssporte shares.
March 19th 2019, 7:03am
portefeuillefun @portefeuillefun
Sold 500 $CLLS at €17.17, now 15k #vssporte shares.
March 19th 2019, 6:03am
ThisLincolnian @ThisLincolnian
Cellectis $CLLS Lifted to Hold at BidaskClub https://t.co/D1ECFadj68
March 19th 2019, 2:03am
TheMarketsDaily @TheMarketsDaily
Cellectis SA Expected to Earn FY2019 Earnings of -$2.90 Per Share $CLLS https://t.co/Jyib1oc7Hi
March 19th 2019, 1:03am
macondailynews @macondailynews
Cellectis SA Expected to Earn FY2019 Earnings of -$2.90 Per Share $CLLS https://t.co/F318NMOXtJ
March 19th 2019, 1:03am
JacobPlieth @JacobPlieth
@DZalkowitz Not this tech, though. I think with these allo projects $CLLS uses shRNA
March 18th 2019, 2:03pm
portefeuillefun @portefeuillefun
Sold 500 $CLLS at $19.53, now 15.5k #vssporte shares.
March 18th 2019, 10:03am
dispatchtribune @dispatchtribune
Cellectis $CLLS – Research Analysts’ Weekly Ratings Changes https://t.co/MhQKxG9uc3
March 18th 2019, 8:03am
AmericanBanking @AmericanBanking
Cellectis $CLLS – Research Analysts’ Weekly Ratings Changes https://t.co/igECg212US #stocks
March 18th 2019, 8:03am
FinZTribune @FinZTribune
Cellectis S.A. $CLLS Trades at $19.31 Forming Double Bottom Chart Pattern https://t.co/gWJKFkbWoV
March 18th 2019, 8:03am
bulletin_en @bulletin_en
At $19.31 Cellectis S.A. $CLLS Forms Bearish Double Bottom https://t.co/vkQxU2y6JH
March 18th 2019, 8:03am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.